NIFTY opened at 16757.10 with a big gap up of 412 points. The index first moved down and then went up and recorded its intraday high almost at the opening tick. Prices face strong resistance there and then turn on the downside. Prices slowly moved down and then saw a sudden decline in the last afternoon to record its intraday low at 16447.90. The index has seen some recovery in the last one and half hours of trading and finally closed at 16594.90 with a gain of 249.55 points or 1.53% up. All the sectoral indices have seen an upside move today except the IT that ended with a minor loss. FMCG, METAL, and REALTY outperformed today and closed with more than 2% gains.
The short-term trend is sideways now and we have 16800 level as resistance and 16200 level as a support for the NIFTY Index. The NIFTY continued moving in a wide intraday range. The volatility index ‘INDIA VIX’ has seen a significant faII but still trading at a level where the volatility will be high. The first sign of low volatile markets will come when the VIX moves below 20. As mentioned yesterday, “Carry forward traders should step aside:·However, intraday traders should look for a trading opportunity on both sides of the market.
BANK NIFTY opened at 35153.95 with a big gap up of 1262 points. The index moved further of the upside and recorded its intraday high at 35374.15. Prices finds strong resistance there and then started drifting downwards. A sharp decline brought prices to its intraday low at 34218.05. Prices have consolidated in the last one and half hour of trading and finally closed at 34400.70 with a gain of 509 points. PSU BANKS outperformed today and closed with a gain of 2.33%.PVT BANKS have underperformed today but closed higher with a gain of 1.80%. Within the index, in terms of points, SBIN contributed the highest while BANDHAN BANK contributed the lowest.
The index has been recording wide intraday range from the last few trading days while the short-term trend changed to sideways due to a sharp upside correction.
|TATASTEEL||1308||BUY||The stock is on the verge of giving the breakout on the intraday as well as the daily chart. The stock can be bought with a stop loss of 1290 and for the target of 1340.|
|GUJGAS||509||SELL||The immediate trend of the script is bearish. There is a negative cross over of moving averages as well as of the indicators therefore it can be sell below 508 with a stop loss of 515 and target of 496.|
|Stock Name||Strike Price||Buy/Sell||CMP||Initiation||Stop Loss||Target||Remarks|
|TCS||3600 PE||BUY||71||CMP||55||100||OI Increase|
|Long Buildup||Short Buildup|
|Stocks||Price||Price%||OI %||OI||Stocks||Price||Price%||OI %||OI|
|ASHOKLEY.Mar 31||106.95||0.05||13.87||45540000||COFORGE.Mar 31||4254.95||-6.8||205.74||1700500|
|IDFC.Mar 31||56.25||0.09||2.31||81390000||GAIL.Mar 31||144.95||-4.58||22.88||31774900|
|M&M.Mar 31||736.5||0.12||6.05||16417100||GUJGASLTD.Mar 31||509.35||-4.53||27.51||3621250|
|WIPRO.Mar 31||585.3||0.16||3.69||33824800||COALINDIA.Mar 31||179.35||-3.89||14.75||35326200|
|MPHASIS.Mar 31||3231.45||0.23||1.64||1665475||INDHOTEL.Mar 31||200.05||-3.59||13.64||17926054|
|Short Covering||Long Unwinding|
|MGL.Mar 31||762.3||0.11||-0.63||3294000||ABBOTINDIA.Mar 31||17577.4||-1.9||-0.08||32650|
|MIDCPNIFTY.Mar 29||6875.1||0.15||-4.76||1500||AUROPHARMA.Mar 31||630.45||-1.14||-0.43||14055750|
|SUNPHARMA.Mar 31||871.15||0.21||-0.06||20507200||MANAPPURAM.Mar 31||121||-0.94||-0.82||23805000|
|TRENT.Mar 31||1150.1||0.26||-0.66||2832575||PFIZER.Mar 31||4427.15||-0.35||-1.61||99125|
|GLENMARK.Mar 31||445.3||0.42||-0.25||7300200||DELTACORP.Mar 31||273.2||-0.24||-0.7||13008800|
TOP DELIVERY PERCENTAGE
|Stocks||Price||%Chg||Total Qty||Delivery||Del %||% Change|
|Abb Limited||2157.95||0.71||145468||0||76.4||Nifty it||35399.1||-0.12||80631|
|Colgate Palmolive (india||1496.95||3.31||745076||0||73.06||India Vix||25.58||-6.88||80631|
|Godrej Cons Products Ltd||710.85||1.26||2212776||0||71.97||Nifty Fmcg||35530.3||3.03||80631|
|Icici Lombard General In||1260.15||1.95||1099064||0||71.38||Nifty Pharma||13077.05||0.14||80631|
|Alembic Pharmaceuticals||722.8||0.09||149939||0||71.32||Nifty Realty||428.2||2.23||80631|
|Itc Ltd.||232||1.2||36132245||0||69.19||Nifty Auto||10019.35||1.9||80631|
|Dabur India Ltd.||545.7||3.33||1658773||0||66.91||Nifty Metal||6161.95||2.28||80631|
|Kotak Mahindra Bank Limi||1754.35||0.88||4188469||0||65.38||Nifty Media||2132.25||0.32||80631|
|Nifty Financial Services||16134.95||1.83||80634|
UPCOMING ECONOMIC DATA
|INR: Industrial Production (YoY) (Jan) on 11th March, 2022
INR: Manufacturing Output (MoM) (Jan) on 11th March, 2022
|•USD: Federal Budget Balance (Feb) on 11th March, 2022|
- RattanIndia Enterprises has forayed into the drone business in the country through its wholly-owned subsidiary NeoSky and expects the commercial rollout of products in the first quarter of 2023, a senior company official said on Thursday. The company has earmarked an initial investment of Rs 100 crore in NeoSky, which will design, manufacture and sell consumer micro drones across India, RattanIndia Enterprises Business Chairperson Anjali Rattan Nashier told PTI.
- India Infrastructure Finance Company Ltd (IIFCL) on Thursday said it has raised Rs 6,000 crore in debt to provide impetus to government’s infrastructure vision. With a view to promote long term infrastructure finance in India, IIFCL after a span of eight years has raised funds from the domestic market through privately placed Non-Convertible Debt Securities for an amount of Rs 5,000 crore with a greenshoe option of Rs 1,000 crore, the company said in a statement.
- Zydus Lifesciences on Thursday said the US health regulator has issued three observations after inspecting its Jarod (Vadodara) based manufacturing facility. The US Food and Drug Administration (USFDA) inspected the injectable facility from February 24 to March 10, 2022. The inspection closed with three observations, the drug firm said in a regulatory filing.
- NMDC on Thursday said it has conducted an e-auction of 8,337 carats rough diamonds produced at its Panna diamond mines in Madhya Pradesh. In a statement, the state-owned miner said the e-auction process received an overwhelming response from Diamond merchants of Surat, Mumbai and Panna.
Source: Economic Times, Indian Express ,Business Today, Livemint, Business Standard, Bloomberg Quint.
|Company Name||Purpose||Ex-Date||Company Name||Purpose||Ex-Date|
|DHANVARSHA||Preferential Issue of shares||11-Mar-22||NIRMITEE||Increase in Authorised Capital;Bonus issue||12-Mar-22|
|MIRCH||Increase in Authorised Capital;Pref. Issue||11-Mar-22||AGIIL||Interim Dividend||14-Mar-22|
|GORANIN||Issue Of Warrants||12-Mar-22||NDASEC||General||14-Mar-22|
|Company Name||Ex-Date||Purpose||Company Name||Ex-Date||Purpose|
|SRTRANSFIN||11-Mar-22||Interim Dividend – Rs. – 12.00||BCG||15-Mar-22||Bonus issue 2:3|
|ARIHCAPM||14-Mar-22||Interim Dividend – Rs. – 0.7500||RAJGLOWIR||15-Mar-22||Stock Split From Rs.10/- to Rs.2/-|
|DICIND||14-Mar-22||Final Dividend – Rs. – 3.00||TVSELECT||15-Mar-22||Interim Dividend – Rs. – 2.00|
|DICIND||14-Mar-22||Special Dividend – Rs. – 2.00||DRCSYSTEMS||16-Mar-22||Stock Split From Rs.10/- to Rs.1/-|
|INFIBEAM||14-Mar-22||Bonus issue 1:1||JINDALSTEL||16-Mar-22||Interim Dividend – Rs. – 1.00|
|NLCINDIA||14-Mar-22||Interim Dividend – Rs. – 1.50||KMSUGAR||16-Mar-22||E.G.M.|
|RKFORGE||14-Mar-22||Stock Split From Rs.10/- to Rs.2/-||METROBRAND||16-Mar-22||Interim Dividend – Rs. – 1.50|
|AIML||15-Mar-22||Stock Split From Rs.10/- to Rs.1/-||RELTD||16-Mar-22||E.G.M.|
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, email@example.com
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing firstname.lastname@example.org with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail email@example.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL